AbbVie is Outperforming the Market this Year So Far. Is Its 16.4x Valuation Attractive?

AbbVie Inc. (NYSE:ABBV) is delivering strong returns this year, with shares surging by over 23% year-to-date. In comparison, the broader market has returned nearly 13% in the same period. Yahoo Finance’s latest data puts AbbVie’s forward P/E at 16.39x, which is considerably different from the company’s trailing P/E of 74.88 because AbbVie’s reported earnings have […]